In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats

Background and purpose: We have shown that in vitro treatment with cannabidiol (CBD, 2 h) enhances endothelial function in arteries from Zucker diabetic fatty (ZDF) rats, partly due to a cyclooxygenase (COX)-mediated mechanism. The aim of the present study was to determine whether treatment with CBD...

Full description

Bibliographic Details
Main Authors: Wheal, Amanda J., Jadoon, Khalid, Randall, Michael D., O'Sullivan, Saoirse
Format: Article
Published: Frontiers Media 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/43898/
_version_ 1848796791260053504
author Wheal, Amanda J.
Jadoon, Khalid
Randall, Michael D.
O'Sullivan, Saoirse
author_facet Wheal, Amanda J.
Jadoon, Khalid
Randall, Michael D.
O'Sullivan, Saoirse
author_sort Wheal, Amanda J.
building Nottingham Research Data Repository
collection Online Access
description Background and purpose: We have shown that in vitro treatment with cannabidiol (CBD, 2 h) enhances endothelial function in arteries from Zucker diabetic fatty (ZDF) rats, partly due to a cyclooxygenase (COX)-mediated mechanism. The aim of the present study was to determine whether treatment with CBD in vivo would also enhance endothelial function. Experimental approach: Male ZDF rats, or ZDF Lean rats, were treated for 7 days (daily i.p. injection) with either 10mg/kg CBD or vehicle (n D 6 per group). Sections of mesenteric resistance arteries, femoral arteries and thoracic aortae were mounted on a wire myograph, and cumulative concentration-response curves to endothelium-dependent (acetylcholine, ACh, 1 nM–100 mM) or endothelium-independent (sodium nitroprusside, SNP, 1 nM–100 mM) agents were constructed. Multiplex analysis was used to measure serum metabolic and cardiovascular biomarkers. Key results: Vasorelaxation to ACh was significantly enhanced in mesenteric arteries from CBD-treated ZDF rats, but not ZDF Lean rats. The enhanced vasorelaxation in ZDF mesenteric arteries was no longer observed after COX inhibition using indomethacin or nitric oxide (NO) inhibition using L-NAME. Increased levels of serum c-peptide, insulin and intracellular adhesion molecule-1 observed in the ZDF compared to ZDF Lean rats were no longer significant after 7 days CBD treatment. Conclusion and implications: Short-term in vivo treatment with CBD improves ex vivo endothelium-dependent vasorelaxation in mesenteric arteries from ZDF rats due to COX- or NO-mediated mechanisms, and leads to improvements in serum biomarkers.
first_indexed 2025-11-14T19:53:35Z
format Article
id nottingham-43898
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:53:35Z
publishDate 2017
publisher Frontiers Media
recordtype eprints
repository_type Digital Repository
spelling nottingham-438982020-05-04T18:46:01Z https://eprints.nottingham.ac.uk/43898/ In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats Wheal, Amanda J. Jadoon, Khalid Randall, Michael D. O'Sullivan, Saoirse Background and purpose: We have shown that in vitro treatment with cannabidiol (CBD, 2 h) enhances endothelial function in arteries from Zucker diabetic fatty (ZDF) rats, partly due to a cyclooxygenase (COX)-mediated mechanism. The aim of the present study was to determine whether treatment with CBD in vivo would also enhance endothelial function. Experimental approach: Male ZDF rats, or ZDF Lean rats, were treated for 7 days (daily i.p. injection) with either 10mg/kg CBD or vehicle (n D 6 per group). Sections of mesenteric resistance arteries, femoral arteries and thoracic aortae were mounted on a wire myograph, and cumulative concentration-response curves to endothelium-dependent (acetylcholine, ACh, 1 nM–100 mM) or endothelium-independent (sodium nitroprusside, SNP, 1 nM–100 mM) agents were constructed. Multiplex analysis was used to measure serum metabolic and cardiovascular biomarkers. Key results: Vasorelaxation to ACh was significantly enhanced in mesenteric arteries from CBD-treated ZDF rats, but not ZDF Lean rats. The enhanced vasorelaxation in ZDF mesenteric arteries was no longer observed after COX inhibition using indomethacin or nitric oxide (NO) inhibition using L-NAME. Increased levels of serum c-peptide, insulin and intracellular adhesion molecule-1 observed in the ZDF compared to ZDF Lean rats were no longer significant after 7 days CBD treatment. Conclusion and implications: Short-term in vivo treatment with CBD improves ex vivo endothelium-dependent vasorelaxation in mesenteric arteries from ZDF rats due to COX- or NO-mediated mechanisms, and leads to improvements in serum biomarkers. Frontiers Media 2017-05-18 Article PeerReviewed Wheal, Amanda J., Jadoon, Khalid, Randall, Michael D. and O'Sullivan, Saoirse (2017) In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats. Frontiers in Pharmacology, 8 . 248/1-248/9. ISSN 1663-9812 cannabinoid sodium nitroprusside vasorelaxation nitric oxide cyclooxygenase ZDF rats http://journal.frontiersin.org/article/10.3389/fphar.2017.00248/full doi:10.3389/fphar.2017.00248 doi:10.3389/fphar.2017.00248
spellingShingle cannabinoid
sodium nitroprusside
vasorelaxation
nitric oxide
cyclooxygenase
ZDF rats
Wheal, Amanda J.
Jadoon, Khalid
Randall, Michael D.
O'Sullivan, Saoirse
In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats
title In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats
title_full In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats
title_fullStr In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats
title_full_unstemmed In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats
title_short In vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of Zucker diabetic fatty rats
title_sort in vivo cannabidiol treatment improves endothelium-dependent vasorelaxation in mesenteric arteries of zucker diabetic fatty rats
topic cannabinoid
sodium nitroprusside
vasorelaxation
nitric oxide
cyclooxygenase
ZDF rats
url https://eprints.nottingham.ac.uk/43898/
https://eprints.nottingham.ac.uk/43898/
https://eprints.nottingham.ac.uk/43898/